Rafferty Asset Management, LLC Bio Rad Laboratories, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$268.26 - $339.48 $15,022 - $19,010	56 Added 2.6%	2,212 $604,000
Q1 2024 May 13, 2024	BUY	$304.11 - $351.99 $8,819 - $10,207	29 Added 1.36%	2,156 $745,000
Q4 2023 Feb 13, 2024	SELL	$269.37 - $365.04 $14,007 - $18,982	-52 Reduced 2.39%	2,127 $686,000
Q3 2023 Nov 13, 2023	BUY	$350.25 - $422.63 $31,872 - $38,459	91 Added 4.36%	2,179 $781,000
Q2 2023 Aug 11, 2023	BUY	$359.49 - $486.4 $59,315 - $80,256	165 Added 8.58%	2,088 $791,000
Q1 2023 May 11, 2023	BUY	$418.69 - $503.0 $33,076 - $39,737	79 Added 4.28%	1,923 $921,000
Q4 2022 Feb 13, 2023	BUY	$351.71 - $456.01 $246,548 - $319,663	701 Added 61.33%	1,844 $775,000
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $254,980 - $348,094	618 Added 117.71%	1,143 $477,000
Q2 2022 Aug 12, 2022	SELL	$463.67 - $597.16 $63,059 - $81,213	-136 Reduced 20.57%	525 $260,000
Q1 2022 May 13, 2022	SELL	$524.57 - $735.42 $34,097 - $47,802	-65 Reduced 8.95%	661 $372,000
Q4 2021 Feb 10, 2022	BUY	$708.84 - $794.68 $29,062 - $32,581	41 Added 5.99%	726 $549,000
Q3 2021 Nov 10, 2021	BUY	$657.71 - $825.77 $157,192 - $197,359	239 Added 53.59%	685 $511,000
Q2 2021 Aug 10, 2021	BUY	$576.64 - $649.04 $12,686 - $14,278	22 Added 5.19%	446 $287,000
Q1 2021 May 10, 2021	BUY	$547.01 - $662.35 $27,897 - $33,779	51 Added 13.67%	424 $242,000
Q4 2020 Feb 10, 2021	SELL	$510.68 - $643.45 $678,693 - $855,145	-1,329 Reduced 78.08%	373 $217,000
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $554,404 - $653,432	1,220 Added 253.11%	1,702 $877,000
Q2 2020 Aug 07, 2020	BUY	$334.87 - $493.06 $161,407 - $237,654	482 New	482 $218,000

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.46B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account